1. Home
  2. SHPH vs APDN Comparison

SHPH vs APDN Comparison

Compare SHPH & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHPH
  • APDN
  • Stock Information
  • Founded
  • SHPH 2012
  • APDN 1983
  • Country
  • SHPH United States
  • APDN United States
  • Employees
  • SHPH N/A
  • APDN N/A
  • Industry
  • SHPH Biotechnology: Pharmaceutical Preparations
  • APDN Other Consumer Services
  • Sector
  • SHPH Health Care
  • APDN Consumer Discretionary
  • Exchange
  • SHPH Nasdaq
  • APDN Nasdaq
  • Market Cap
  • SHPH 2.2M
  • APDN 2.0M
  • IPO Year
  • SHPH 2022
  • APDN N/A
  • Fundamental
  • Price
  • SHPH $0.41
  • APDN $1.72
  • Analyst Decision
  • SHPH
  • APDN Strong Buy
  • Analyst Count
  • SHPH 0
  • APDN 1
  • Target Price
  • SHPH N/A
  • APDN $75.00
  • AVG Volume (30 Days)
  • SHPH 260.4K
  • APDN 2.6M
  • Earning Date
  • SHPH 05-12-2025
  • APDN 05-09-2025
  • Dividend Yield
  • SHPH N/A
  • APDN N/A
  • EPS Growth
  • SHPH N/A
  • APDN N/A
  • EPS
  • SHPH N/A
  • APDN N/A
  • Revenue
  • SHPH N/A
  • APDN $3,736,873.00
  • Revenue This Year
  • SHPH N/A
  • APDN $57.08
  • Revenue Next Year
  • SHPH N/A
  • APDN $40.00
  • P/E Ratio
  • SHPH N/A
  • APDN N/A
  • Revenue Growth
  • SHPH N/A
  • APDN N/A
  • 52 Week Low
  • SHPH $0.33
  • APDN $1.45
  • 52 Week High
  • SHPH $4.71
  • APDN $450.00
  • Technical
  • Relative Strength Index (RSI)
  • SHPH 33.79
  • APDN 22.14
  • Support Level
  • SHPH $0.35
  • APDN $1.45
  • Resistance Level
  • SHPH $0.41
  • APDN $2.39
  • Average True Range (ATR)
  • SHPH 0.05
  • APDN 0.34
  • MACD
  • SHPH 0.01
  • APDN 0.07
  • Stochastic Oscillator
  • SHPH 33.96
  • APDN 14.39

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

About APDN Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Share on Social Networks: